Literature DB >> 29955891

Human Biomarkers of Outcome Following Rift Valley Fever Virus Infection.

Anita K McElroy1,2,3, Jessica R Harmon1, Timothy Flietstra1, Stuart T Nichol1, Christina F Spiropoulou1.   

Abstract

Rift Valley fever virus is an arbovirus found in Africa and the Middle East. Most infected individuals experience a mild self-limiting illness; however, some develop severe disease including hepatitis, hemorrhagic fever, or encephalitis. The biological reasons for these marked differences in disease manifestation are unknown. In this study, we evaluate 32 biomarkers in serum of 26 patients from an outbreak that occurred in Saudi Arabia in 2000-2001. Eleven biomarkers correlated with viral RNA. Thirteen biomarkers were associated with a fatal outcome. No associations of biomarkers and hemorrhage or central nervous system disease were identified in this cohort.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29955891      PMCID: PMC6455937          DOI: 10.1093/infdis/jiy393

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

Review 1.  Selectins: initiators of leucocyte adhesion and signalling at the vascular wall.

Authors:  Rodger P McEver
Journal:  Cardiovasc Res       Date:  2015-05-20       Impact factor: 10.787

2.  Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment.

Authors:  Dionna Scharton; Kevin W Bailey; Zachary Vest; Jonna B Westover; Yohichi Kumaki; Arnaud Van Wettere; Yousuke Furuta; Brian B Gowen
Journal:  Antiviral Res       Date:  2014-01-31       Impact factor: 5.970

3.  Ebola hemorrhagic Fever: novel biomarker correlates of clinical outcome.

Authors:  Anita K McElroy; Bobbie R Erickson; Timothy D Flietstra; Pierre E Rollin; Stuart T Nichol; Jonathan S Towner; Christina F Spiropoulou
Journal:  J Infect Dis       Date:  2014-02-12       Impact factor: 5.226

4.  Proinflammatory adaptive cytokine and shed tumor necrosis factor receptor levels are elevated preceding systemic lupus erythematosus disease flare.

Authors:  Melissa E Munroe; Evan S Vista; Joel M Guthridge; Linda F Thompson; Joan T Merrill; Judith A James
Journal:  Arthritis Rheumatol       Date:  2014-07       Impact factor: 10.995

5.  Highly sensitive and broadly reactive quantitative reverse transcription-PCR assay for high-throughput detection of Rift Valley fever virus.

Authors:  Brian H Bird; Darcy A Bawiec; Thomas G Ksiazek; Trevor R Shoemaker; Stuart T Nichol
Journal:  J Clin Microbiol       Date:  2007-09-05       Impact factor: 5.948

6.  N-acetylcysteine in children with acute liver failure complicating dengue viral infection.

Authors:  M P Senanayake; M D C J P Jayamanne; I Kankananarachchi
Journal:  Ceylon Med J       Date:  2013-06

Review 7.  Gene of the month: HGF.

Authors:  Ana Belen Fajardo-Puerta; Mireia Mato Prado; Adam E Frampton; Long R Jiao
Journal:  J Clin Pathol       Date:  2016-04-12       Impact factor: 3.411

8.  Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics.

Authors:  Tariq A Madani; Yagob Y Al-Mazrou; Mohammad H Al-Jeffri; Amin A Mishkhas; Abdullah M Al-Rabeah; Adel M Turkistani; Mohammad O Al-Sayed; Abdullah A Abodahish; Ali S Khan; Thomas G Ksiazek; Osama Shobokshi
Journal:  Clin Infect Dis       Date:  2003-09-23       Impact factor: 9.079

9.  Serum levels of inflammatory cytokines in Rift Valley fever patients are indicative of severe disease.

Authors:  Petrus Jansen van Vuren; Sharon Shalekoff; Antoinette A Grobbelaar; Brett N Archer; Juno Thomas; Caroline T Tiemessen; Janusz T Paweska
Journal:  Virol J       Date:  2015-10-06       Impact factor: 4.099

Review 10.  Biomarkers of endothelial activation/dysfunction in infectious diseases.

Authors:  Andrea V Page; W Conrad Liles
Journal:  Virulence       Date:  2013-04-19       Impact factor: 5.882

View more
  3 in total

1.  Neutrophil and macrophage influx into the central nervous system are inflammatory components of lethal Rift Valley fever encephalitis in rats.

Authors:  Joseph R Albe; Devin A Boyles; Aaron W Walters; Michael R Kujawa; Cynthia M McMillen; Douglas S Reed; Amy L Hartman
Journal:  PLoS Pathog       Date:  2019-06-20       Impact factor: 6.823

2.  NSG-Mice Reveal the Importance of a Functional Innate and Adaptive Immune Response to Overcome RVFV Infection.

Authors:  Lukas Mathias Michaely; Melanie Rissmann; Markus Keller; Rebecca König; Felicitas von Arnim; Martin Eiden; Karl Rohn; Wolfgang Baumgärtner; Martin Groschup; Reiner Ulrich
Journal:  Viruses       Date:  2022-02-08       Impact factor: 5.048

3.  Clinical manifestations of Rift Valley fever in humans: Systematic review and meta-analysis.

Authors:  Zacchaeus Anywaine; Swaib Abubaker Lule; Christian Hansen; George Warimwe; Alison Elliott
Journal:  PLoS Negl Trop Dis       Date:  2022-03-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.